The Guggenheim Group has lowered its target price for Sinovac Group from $388 to $350.

Guggenheim Securities lowered the target price of Cigna Group from $388 to $350, while maintaining a "buy" rating. The new target price implies a 33% increase from the previous closing price. Cigna Group's quarterly earnings and sales, announced on July 31, exceeded expectations.